MiMedx Group, Inc. (NASDAQ:MDXG) is one of the Best 52-Week Low Penny Stocks to Invest In. On February 25, MiMedx Group, Inc. (NASDAQ:MDXG) delivered record quarterly and full-year revenue and profitability. This was driven by the company’s wound care and surgical segments, both delivering double-digit growth.
The company grew its Q4 revenue by 27.11% year-over-year to reach $118.1 million and topped the Street’s target by $11.32 million. The EPS of $0.10 also exceeded expectations by $0.01. The growth was driven by 28% year-over-year increase in wound care and 25% increase in surgical segment revenue. Notably, the gross profit margins improved 200 basis points to reach 86% for Q4, driven by better product mix compared to a year ago.
For fiscal 2026, the company expects revenue in the range of $340 million to $360 million, while the adjusted EBITDA margin is expected in the range of mid to high teens.
MiMedx Group, Inc. is a U.S. biomedical company that develops and distributes advanced placental tissue allografts for wound care, surgical, and burn applications. Its products, using proprietary processing methods, help clinicians treat chronic and hard-to-heal wounds.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
